Navigation Links
Sinovac Requests Extension for Annual Shareholders Meeting
Date:12/13/2007

BEIJING, Dec. 13 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it has notified the Listing Qualifications Department at the American Stock Exchange that the Company will defer its 2007 annual stockholders meeting to no later than April 30, 2008.

The Company originally scheduled its 2007 annual stockholders meeting in August 2007. The meeting was postponed because the Company could not form the necessary quorum, which is 50% of the outstanding shares based on the Company's by-laws. The Company does not believe that it will be able to form the necessary quorum to hold the 2007 annual meeting by year-end, and it is continuing to evaluate different options as an Antigua corporation and a foreign private issuer.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(TM) (hepatitis A), Bilive(TM) (combined hepatitis A and B) and Anflu(TM) (influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, and Japanese encephalitis. Additional information about Sinovac is available on its website, http://www.sinovac.com. To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
3. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
4. Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension
5. AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB
6. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
7. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
8. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
10. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
11. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economic C...Canada (Vocus) November 25, 2009 -- Ambassador to ...avid Appia, French Ambassador for International In...ance Agency ,To view a biography of David Appia go...dor Appia is available to meet with press to discu...
(Date:11/25/2009)...EIJING,Nov.25/PRNewswire-Asia/--SinovacBiotechLtd....uncedtodaythatitexecuted,ajointventure(JV)agreemen...td.(SinovacDalian).TheJVwillresearch,develop,produ...ntributeitsexpertise,andexperienceindevelopingandc...llbringitslanduserights,manufacturingfacilitiesand...
(Date:11/24/2009)...elease is available in German . , Whether i...ds: RFID tags (Radio Frequency Identification) are.... They make it possible to label objects or goods .... The appropriate scanner can read and process the...affixed to goods under production conditions of up...
(Date:11/24/2009)... The New York investment bank KTA ...EU) has agreed an AU$6.7 mil convertible note priv...The private placement was arranged by KTA Capital ... , New York (PRWEB) Novem...t bank KTA Capital, LLC ("KTA Capital") ...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... infancy, stem cell therapy market to grow rapidly...THAM, Mass., Sept. 13 Millennium Research Group,(... cell therapy market in,its US Markets for Stem Ce...t although the market for stem cell therapies is i...e approved in the US. Today, only two products,are...
... Public and Private Life Science Companies from ...IEGO, Sept. 13 BIOCOM, the association for the,So... to announce that its,second annual BIOCOM Investo...t Del Mar from Oct. 31-Nov. 2, 2007. Featuring al...medical,device companies, the BIOCOM Investor Conf...
...ept. 13 Abaxis, Inc.,(Nasdaq: ABAX ), a medical ... analysis systems, announced today that Clint Seve...i & Company, LLC Sixth Annual San,Francisco Instit...mber 24,2007 at 11:35 a.m. Pacific Time at The Rit...baxis develops, manufactures and markets portable ...
Other Biology Technology:Stem Cell Therapy to Skyrocket by 2017 2BIOCOM Announces Second Annual Investor Conference 2
(Date:11/25/2009)...Athens, Ga. Bacteria don,t have easy lives. In ad...e bugs, they have natural enemies called bacteriop...h every two days. , Still, bacteria and another...covered in extreme environments such as deep-sea v...t because they have a built-in defense system that...
(Date:11/25/2009)... Dr. Sarit Larisch, Head of the Cell Death Resear...ent of Biology, has been awarded the prestigious J...earch exploring the cause of brain cell damage in ...ach year to scientists in support of innovation an...d officially conferred earlier this month at an ev...
(Date:11/25/2009)...Over the course of a lifetime, the heart pumps som... the order to do this, the muscle fibers of the he...up headed by Dr. Wolfgang Rottbauer, vice chair of...ersity Hospital (Chairman: Prof. Dr. H. A. Katus),...the stability of the smallest muscular unit, the s...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Henk Hoogenkamp Accomplished Author and Food Ingredient Scientist Joins NutraCea as Executive Advisor on the Utilization of Stabilized Rice Bran in 14854 1Henk Hoogenkamp Accomplished Author and Food Ingredient Scientist Joins NutraCea as Executive Advisor on the Utilization of Stabilized Rice Bran in 14854 2Henk Hoogenkamp Accomplished Author and Food Ingredient Scientist Joins NutraCea as Executive Advisor on the Utilization of Stabilized Rice Bran in 14854 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 1Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 5New combination therapy could deliver powerful punch to breast cancer 61445 1New combination therapy could deliver powerful punch to breast cancer 61445 2
...young Jim Sacchettini to become a biochemist, you ...But that story,s for later., , Instead, ponder wh...nfectious diseases that not long ago were consider... and malaria, for instance. , , Sacchettini saw t...there in 1990 from St. Louis, Mo., after earning h...
...l Medical Center immunologist and blood and marrow...serve as the study co-chair for a new national cli...l cord blood transplants for severe sickle cell ...20 other medical institutions in the first-ever Ph...sful, the Sickle Cell Unrelated Transplant (SCURT)...
...eloped a new gene silencing technology that could ...opment of certain diseases. This technology could ...sfunction plays a role. The groundbreaking researc...Chairman of the Department of Structural and Chemi... findings, which will be published in the Septembe...
Other Biology News:College cocktails lead to science career 2Children's national co-leads nationwide study of landmark sickle cell treatment 2
...trix Metalloproteinase-2, Hinge Region By immunobl... native protein. It reacts with free MMP-2 or MMP-...fered aqueous glycerol solution Solution in 0.01 ...% glycerol and 15 mM sodium azide. synthetic pepti...
Human Exodus-2 from MBL International
Anti-IRS 2, phospho (Ser731) Polyclonal Antibody, Unconjugated from BioSource International (Invitrogen)
Power Supply for i-MyRun from Cosmo Bio Co., Ltd.
Biology Products: